"I really think this is a calling," said Allyson Letendre Petrone. "I don't think you go into oncology care and take care of ...

In contrast, the experts noted that several recent FDA approvals introduced first-in-class therapies to the oncology landscape. 1 Among these are menin inhibitors, which block the interaction between ...

MemorialCare Medical Group has appointed four accomplished physicians as Medical Directors: Rachael Lopez, M.D., Medical Director of Obstetrics and Gynecology; Irina Sachelarie, M.D., Medical Director ...

In this video, Leo I. Gordon, MD, FACP, discusses highlights from a debate at Lymphoma, Leukemia & Myeloma Congress on the evolving treatment landscape for relapsed or refractory diffuse large B-cell ...

The 5-year lung cancer survival rate has increased more than 25% over the past decade, highlighting the impact of increased ...

The regimen of bexmarilimab and azacitidine (Vidaza) demonstrated a highly promising efficacy profile with a manageable ...